You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

 

Online download statistics by month:

Online download statistics by month: June 2022 to September 2025

AbstractFullPdf
Jun 2022592599245
Jul 2022379389173
Aug 202224825278
Sep 202224024363
Oct 202222422558
Nov 202217417551
Dec 202215415441
Jan 202316216336
Feb 202316616862
Mar 202314114246
Apr 202313613651
May 202315115247
Jun 2023747424
Jul 2023696939
Aug 2023636428
Sep 2023707224
Oct 2023707134
Nov 2023868627
Dec 2023787931
Jan 2024596129
Feb 2024585834
Mar 2024595960
Apr 2024595947
May 2024646425
Jun 2024696736
Jul 2024545429
Aug 2024393631
Sep 2024737148
Oct 2024525219
Nov 2024646748
Dec 2024717237
Jan 2025626223
Feb 202510910934
Mar 202510010026
Apr 202517918037
May 2025636341
Jun 2025434328
Jul 2025110
Sep 2025110
Total455645921790